Skip to main navigation Skip to search Skip to main content

Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance (Oncogene, (2018), 37, 29, (3981-3997), 10.1038/s41388-018-0238-8)

  • Wei Zhou
  • , Wei Sun
  • , Mingo M.H. Yung
  • , Sheng Dai
  • , Yihua Cai
  • , Chi Wei Chen
  • , Yunxiao Meng
  • , Jennifer B. Lee
  • , John C. Braisted
  • , Yinghua Xu
  • , Noel T. Southall
  • , Paul Shinn
  • , Xuefeng Huang
  • , Zhangfa Song
  • , Xiulei Chen
  • , Yan Kai
  • , Xin Cai
  • , Zongzhu Li
  • , Qiang Hao
  • , Annie N.Y. Cheung
  • Hextan Y.S. Ngan, Stephanie S. Liu, Stephanie Barak, Jing Hao, Zhijun Dai, Alexandros Tzatsos, Weiqun Peng, Huadong Pei, Zhiyong Han, David W. Chan, Wei Zheng, Wenge Zhu
  • George Washington University
  • Zhejiang University
  • National Institutes of Health
  • The University of Hong Kong
  • Xi’an Jiaotong University

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Oncogenehttps://doi.org/10.1038/s41388-018-0238-8, published online 17 April 2018 Following the publication of this article, the authors noted two inadvertent errors in Figure 5c, which occurred during figure assembly. The JAK2 immunoblot was mistakenly used in place of the STAT5 immunoblot, and the GAPDH loading control was inadvertently taken from a different blot generated from the same cell lysates. The corrected Figure 5c is provided below. The authors confirm these errors do not affect the underlying experimental data or the conclusions of the study and apologise for any inconvenience caused by these errors. Figure 5 (Figure presented.).

Original languageEnglish
Pages (from-to)2072-2073
Number of pages2
JournalOncogene
Volume45
Issue number21
DOIs
StatePublished - 11 Jun 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance (Oncogene, (2018), 37, 29, (3981-3997), 10.1038/s41388-018-0238-8)'. Together they form a unique fingerprint.

Cite this